医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

SYDNEY

Australian Medtech Services (AMS) today announced the appointment of Eva Reinander as Vice President of Asia Pacific. AMS is a strategic planning and concierge service dedicated to assisting U.S.-based medical device companies with commercialization, fundraising and research and development efforts in the Asia Pacific region.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160108005506/en/

Eva Reinander, Vice President of Asia Pacific, Australian Medtech Services (Photo: Business Wire)

“With more than 20 years of global medical device commercialization experience and a proven track record of success, Eva will be instrumental in leading commercialization efforts on behalf of our clients throughout Asia Pacific,” said Trevor Moody, Managing Director of AMS. “Based on her extensive medtech industry experience and relationships throughout key markets in Asia Pacific, Eva is the ideal choice to take AMS to the next level.”

Eva started her career in Sweden with diagnostic company Synectics Medical, which was later acquired by Medtronic. In 1998, Eva joined ArthroCare as Operations Manager and established its international headquarters. There she was responsible for logistics, regulatory, quality and marketing outside of the U.S. and – as the business expanded – she oversaw the sales and marketing activities for the spine product line in international markets. In 2008, Eva moved to Australia and served as Managing Director for ArthroCare’s Australia and New Zealand commercial operation where she was responsible for determining strategic vision, management and total profitability for the entity. In 2013, Eva was promoted to further cultivate ArthroCare’s growth in Asia Pacific by directing the organization to ensure achievement of overall financial and strategic objectives. ArthroCare was subsequently acquired by Smith & Nephew. Eva was a scholar athlete and holds a bachelor of science in marketing and an MBA from the University of Utah.

With a market of $88B growing at 8 percent annually, the Asia Pacific medical device market is increasingly becoming an important focus for both near-term sales and long-term strategic value. The market is forecasted to be larger than the EU by 2020. However, because the Asia Pacific healthcare landscape is complex and highly fragmented, new entrants need a trusted partner to navigate this region.

AMS provides a unique, comprehensive concierge service which includes:

• Upfront strategic planning to identify the most attractive target countries in the Asia Pacific region. In-depth consideration is given to market size, availability of key opinion leaders, clinical and reimbursement requirements, availability of distributors and other in-country partners
• Launch planning, including selecting optimum in-country partners such as distributors, regulatory and reimbursement consultants, key opinion leader relationships, clinical resources etc.
• Commercialization execution including managing all aspects of sales and marketing, logistics, clinical support, etc.

“The vast AMS network and resources provide an unparalleled partnership opportunity for U.S. medical device companies looking to expand into the Asia Pacific region,” Eva Reinander said. “I am excited to join the AMS team and lead the efforts that will help bring these innovative medical devices to this growing market.”

About Australian Medtech Services

Australian Medtech Services (AMS) supports early and late-stage medical technology companies focused on commercialization within the Asia Pacific region. As a fully integrated Asia Pacific service provider, AMS is committed to being a trusted extension of each client’s team. Partnering with AMS allows companies to deliver full strategic focus on the Asia Pacific region with a minimum distraction of internal resources. Entering the Asia Pacific market requires long-term commitment and capital. As a loyal partner, AMS will share the risk with regard to business growth in this region. A portfolio company of MH Carnegie & Co. one of Australia’s leading venture capital and private equity firms, AMS has unique access to capital to facilitate these partnerships. For more information, visit the company’s web site: http://www.australianmedtechservices.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160108005506/en/